These stem cell news blog pages contain information about obtaining Optimal Health, types of stem cells, including adult stem cells, and
a new wellness category called “Adult Stem Cell Enhancers”.
In honoring all the legal guidelines of the companies and products referenced..ONLY Compliant websites and information are listed within these pages.
Stem Cell News Statements concerning Adult stem cell releaser supplements and circulation enhancers have NOT been evaluated by the Food and Drug Administration. Any products mentioned are not intended to diagnose, treat, cure or prevent ANY disease. Please enjoy your "Stem Cell Tour" of your body’s Renewal System.
Stem Cell News .. Adult Stem Cell Releaser Supplements and Circulation Enhancers Available World-Wide
Testimonials How More Adult Stem Cells and More Oxygen Regenerate the Body FASTER !
Stem Cell Update ... M.D.'s Can't be Wrong!
Vital Stem Cell information
Adult stem cell news about cures and treatments for more than 70 diseases that are involved in almost 1,300 human clinical trials is being broadcast around the world.
Scientists also keep discovering more adult stem cell news that adult stem cells are capable of creating a wider variety of mature cells. Perhaps the most promising Stem Cell announcement was made in the January issue of Nature Biotechnology.
Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine, reported that stem cells in the amniotic fluid that fills the sac surrounding the fetus may be just as versatile as embryonic stem cells. At the same time they maintain all the advantages that have made adult stem cells such a success.
This has caused great consternation on the part of those seeking increased taxpayer embryonic stem cell funds. The reason is that there are currently no practical applications for this type of cell. There hasn't even been a single clinical trial involving them. Researchers admit we won't have approved embryonic stem cell treatments for at least 10 years.
One advantage of embryonic stem cells has been that most types of adult stem cells cannot be multiplied outside of the body for very long, while embryonic ones may replicate in the lab indefinitely. But Atala's new amniotic stem cells grow as fast outside the body as embryonic stem cells (doubling every 36 hours), and he's now been growing the same cell line for two years, with no indication of slowing.
That leaves embryonic stem cells with only one possible advantage — potential. Embryonic stem cells can be "differentiated" into all three "germ layers," or subtypes of cell. That means they should be able to be made into all of the 220 types of cells in humans. For a long while, adult stem cells were believed to be only capable of differentiation to a limited number of mature cells, depending on the type of adult stem cell with which you start.
For example,it is stem cell news to discover a marrow cell could become any number of types of marrow or blood cells, but it couldn't become a muscle cell. That's a different germ layer.
Yet it's been virtually a state secret that for over five years researchers, beginning with a team headed by physician Catherine Verfaillie of the University of Minnesota Stem Cell Institute, have been reporting numerous types of adult stem cells (she used those from marrow) that in the lab could form mature cells from three germ layers.
Experiments around the world have clearly shown that this adult stem cell news is Life-changing. One germ layer can be converted into those of another in a living human, such as those that turned marrow cells into heart muscle and blood vessels in live humans.Now that is Big Stem cell News.
That said, amniotic stem cells may be the most easily differentiated of all — as well as among the easiest to extract in large amounts. Indeed, they are routinely recovered with a hypodermic needle during amniocentesis. While it's widely believed that this procedure slightly increases the chance of miscarriage, a sizable study last November of 35,000 women who underwent mid-trimester testing found "no significant difference in loss rates between those undergoing amniocentesis and those not undergoing amniocentesis."
More Stem Cell News
There are over 4 million births each year in the United States, yet Atala calculates that merely 100,000 amniotic stem cell specimens could supply 99 percent of the U.S. population's needs for perfect matches for transplants. (That assumes a perfect match is even needed.)
About 700,000 amniocentesis procedures are performed in the United States and Western Europe each year.
Some embryonic stem cell researchers have downplayed the Atala findings. The work will "still require a lot of replication from other groups before they can be conclusive," Stephen Minger, an embryonic stem cell scientist identified only as a "lecturer in stem-cell biology" told a British newspaper about this Stem cell news. "They have only shown that these particular stem cells can turn into a couple of different types of other stem cells. I would say that a hell of a lot more work is required." Other media outlets would say the same. Newsweek International claimed, "Many scientists are quick to emphasize that comprehensive human trials are still many years away."
The New York Times refused even to allow people to read between the lines — they simply never reported the Stem Cell News about Atala's work. When a reader complained to the "Public Editor," an online ombudsman, about the omission, the Times responded that its genetics reporter, Nicholas Wade, "looked at the Atala paper last week and deemed it a minor development." Wade said of the paper, "It reports finding 'multipotent' stem cells in amniotic fluid. Multipotent means they can't do as much as bona fide embryonic stem cells (which are called 'pluripotent')."
Neither Minger nor Newsweek nor Wade could be more wrong. As Atala told PBS' Online NewsHour about his take on the Stem cell news... , "We have been able to drive the cell to what we call all three germ layers, which basically means all three major classes of tissues available in the body, from which all cells come from." I pointed out in a response to The New York Times posting that merely reading the online abstract of the Atala paper indicated the same. Of course, this is the same paper that told readers in 2004 that there were no cures or treatments with adult stem cells. Not 70+ cures or treatments, some dating back half a century — none. It is neither paranoia nor exaggeration to say that The New York Times is engaged in a stem-cell cover-up.
What makes all of this worse is that Atala's work actually is a replication of numerous studies. He's just taken the research further and pulled his cells from amniotic fluid, whereas others have pulled the identical cells from the placenta. Amniotic and placenta stem cells are the same, as Atala himself noted. And as to human trials being "many years away," Newsweek is correct only if "years away" means "years ago." The New England Journal of Medicine carried one paper on a placenta stem cell trial back in 1996 and another paper two years later. There's been one ongoing clinical trial since 2001 to treat sickle cell anemia.
The Washington Post's Rick Weiss, who has been accused of boosterism for embryonic stem cell research, tried to find a middle ground, saying that "The new [sic] cells are adding credence to an emerging consensus among experts that the popular distinction between embryonic and 'adult' stem cells — those isolated from adult bone marrow and other organs — is artificial."
Actually, what's "artificial" is the term "adult stem cell," which worked fine not so long ago when all adult stem cells were all pulled from bone marrow, but is confusing now that they're being extracted from placentas, amniotic fluid, and umbilical cords, which aren't exactly "adult" sources. But for discussions both scientific and moral, stem cells can still be broken down between the embryonic and the non-embryonic.
More Stem cell news reports that scientifically, all embryonic stem cells tend to become cancerous; they require permanent, dangerous, immunosuppressive drugs because the body rejects them as foreign; and they are difficult to differentiate into the needed type of mature cells.
Non-embryonic stem cells, however, do not become cancerous; they are far less likely to cause rejection (especially the youngest, including umbilical cord and amniotic/placenta); and they have been used therapeutically since the late 1950s (originally for leukemia) because they have the amazing ability to form the right type of mature cell merely upon being injected into a body that needs that type of cell.
It is these biological differences that have held embryonic stem cell research back, not a lack of federal funds. As stem-cell researcher Malcolm Alison of the University of London told the Daily Mail, the amniotic cells "appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."
For all the talk over the morality of using human embryos in medicine .. the vital stem cell news is that another moral issue at play: Nonembryonic stem cell researchers are already performing miracles, such as growing new heart and liver tissue and treating multiple sclerosis — all in living humans. Yet they struggle to get federal funds for their research.
Given the growing number of state initiatives that fund embryonic stem cell, but not non-embryonic stem cell, research and given that overall National Institutes of Health funding increases are unlikely anytime soon, is it truly moral to take away funds from a technology that's been saving lives for half a century in favor of another technology that promises nothing but "promise"?
Stem Cell News .. Stem Cell Releasers .. a Brand New Nutrition Catagory
Are YOU a consumer of Vitamins and Nutrition products? Then this Stem Cell News Update is for you.
Driven by rising consumer demand and a growing body of supporting research, the nutrition industry has evolved to considerably more advanced levels in recent years. Go see for Yourself…, just walk down the aisles of your nearest health food store ..or Wal-Mart.. or Any Drug store..and even, 24 Hr. Gas stations!
Once limited to a few basic vitamins and minerals such as Vitamin C and calcium, their shelves now boast literally hundreds of different nutritional supplements – all the way from your age-old basics to a whole plethora of exotic-sounding antioxidants and super juices.
But no matter how different all these products may seem at first glance, they all have one common purpose: to provide extra nourishment or protection to existing, already-functioning cells within the body’s tissues.
Enter the latest Stem cell News... "stem cell enhancers" – and the World’s first Stem Cell Releaser Supplements in capsules, tablets,granules,and skin serums.
Launched in the USA, in 2005, this powerful, new category of nutritional supplements, is not only here to stay, but it could literally alter the entire nutrition industry.
Already PROVEN since 2005 and sold in over 53 Countries, this Patented Stem Cell Releaser, is recommended by Doctors and has articles published in top scientific and medical journals, documenting it’s releasing over 4 Million stem cells into your blood stream within 90 minutes of taking 2 capsules.
YES.. rather than simply nourishing or protecting existing tissue cells, stem cell enhancers do something completely different: they support the release of your Very OWN adult stem cells from Your Bone Marrow, into the bloodstream.
This Stem cell news is huge, because adult stem cells are at the very core of the body’s natural renewal process! Because they can take on the characteristics of many different types of tissue cells in times of need, recent scientific data shows that larger numbers of circulating adult stem cells equate to greater health and wellness.
The way adult stem cells function is that they are continually released by the bone marrow into the bloodstream, where they circulate until being chemically signaled by tissues in need. Following the chemical signal, they flow to the tissue in need and migrate into it. It is here that the "magic" happens … the stem cells take on the same characteristics as the existing cells and initiate the growth process, thereby naturally "renewing" the tissue! They can become a liver cell.. a brain cell ,a heart cell..a lung cell ..etc.. etc…
The first clinically proven natural stem cell enhancer and stem cell mobilizer on the market is a patented concentrate and its results are impressive to say the least. Not surprising, because a recently published study showed an increase of millions MORE new circulating stem cells in the blood, within MINUTES, after ingesting 2 all natural capsules.
You know Stem Cells are in the NEWS almost every day. Whether you’re an entrepreneur wanting to capitalize on the massive Stem Cell Enhancer tidal wave, a health-conscious consumer, or an Athlete on any level, wanting to have OPTIMAL health, improved performance and faster recovery, you owe it to yourself research stem cell releaser and liquid stabilized oxygen supplements.
STEM CELL NEWS .... Professional Athletes Renew and Recover FAST!
STEM CELL NEWS
By BILL PENNINGTON
The latest curative leap to heal professional athletes and weekend warriors alike may sound like science fiction, but it could transform sports medicine. Some doctors and researchers say that in a few years the use of primitive stem cells from infants’ umbilical cord blood could grow new knee ligaments or elbow tendons creating a therapy that becomes the vanguard of sports injury repair.
Already, making stem cell news, are sports agents that are preparing to advise clients about banking stem cells from their offspring or from tissue taken from their own bodies as an insurance policy against a career-ending infirmity. Stem cell blood banks are promoting the benefits of stem cell therapies for the practical healing and rehabilitation of tendons, ligaments, muscle and cartilage. There are skeptics in the medical community who wonder how soon the technology will be viable, but enthusiastic advocates of the therapies say the time is near.
“It’s not a pie in the sky notion,” said Dr. Scott Rodeo, an orthopedist and award-winning research scientist at Manhattan’s Hospital for Special Surgery. “Maybe it’s not going to happen next year, but a three-to-five-year horizon is not unreasonable.”
Dr. Rodeo has already practiced these technologies in laboratory surgeries on rats, methods that will be especially useful when reconstructing the knee’s anterior cruciate ligament and the shoulder’s rotator cuff. Both are common sports maladies that can be particularly daunting to surgeons because the body generally does not mend or restore the damaged tissue after these injuries.
“In each case, there was promising stem cell news that the stem cells clearly have some beneficial role in inducing tissue regeneration,” said Dr. Rodeo, who is also a team physician with the Giants and a former United States Olympic team doctor.
Some scientists say now is the time to safeguard athletic prodigies, even kindergartners.
“If you have a child who has exceptional athletic talent at the age of 5 or 6, you might want to get a muscle or fat biopsy to draw and freeze some young stem cells,” said Dr. Johnny Huard, the director of the Stem Cell Research Center of the Children’s Hospital of Pittsburgh and a leading gene therapy researcher, related more stem cell news “To have a pool of stem cells already removed would be enormously valuable. The practical use might be years away, but that’s the future of sports medicine.”
The kinds of stem cell therapies being researched for the most part do not involve the politically sensitive use of embryonic stem cells. But they could involve using harvested adult stem cells, stem cells saved from a child at birth or cells from what may someday be a national bank of donated stem cells derived from umbilical cord or placental stem cells.
While the latest stem cell news is showing that therapies have gone beyond the theoretical stage, not everyone in orthopedics is convinced they will be useful in treating top athletes or anyone else.
Dr. Regis O’Keefe, spokesman for and Fellow of the American Academy of Orthopaedic Surgery, said attempts to use regenerated cartilage in knees has so far been “not highly effective.” He noted that there have been no peer-reviewed studies for many of the proposed therapies and limited experimentation in humans.
“There is a potential benefit but it’s going to take years of clinical trials to acquire the scientific knowledge to know this is better than the current alternatives,” said Dr. O’Keefe, who directs musculoskeletal research at the University of Rochester Medical Center. “And without those trials we also cannot properly evaluate the risks.”
Dr. Freddie Fu, a pioneering orthopedic surgeon with the University of Pittsburgh Medical Center, said that is refreshing stem cell news ...
“You have to answer safety questions and look for side effects,” he said. “It will also be quite expensive. Then again, knowing professional athletes, none of that will stop them. They will always be willing to try anything to help them play.”
With stem cell technology advancing, some are acting now to prepare for the wealth of restorative possibilities. Five professional soccer players had their children’s stem cells frozen at birth and stored in a Liverpool stem cell bank, according to a story last year in The Sunday Times of London. One of the players called the stem cells a potential repair kit for a career-threatening injury.
Stem cell therapies could do more than refurbish joints, they could help build muscle in elite athletes and increase other physical capacities at a pace and proficiency not conventionally attainable.
“There is a performance-enhancing possibility to all this,” said Dr. Huard, who added that he has met with doping officials who are trying to prepare for the new technology. “It might not be detectable because nothing is unnatural — they are your own cells. I don’t think you could turn a bad athlete into a super athlete but could you provide the edge that turns an Olympic silver medal winner into an Olympic gold medal winner? I think you could.
“At the same time, this stem cell news ,will reveal the engineering of the body can hold up under the strain of competition at that level. How will it work in an intense, high impact situation like a pro football game?”
Arthur Caplan, director of the Center of Bioethics at the University of Pennsylvania, believes prosperous professional athletes will view the emerging stem cell technology as a fountain of youth.
“It all sounds good to them,” Caplan said. “They’ll charge in head first. But there’s danger in that.”
Leigh Steinberg, a veteran sports agent, conceded that the nation’s top sports stars would zealously pursue each orthopedic breakthrough.
“For good or ill, athletes have always been in the forefront of every new medical technique,” Steinberg said. “Whether it’s the use of human growth hormone or arthroscopic surgery, they are the workers in society whose livelihood most depends on their physical condition. If this stem cell news and medicine is proven out and it’s the difference between being able to play four more years at $8 million a year, every athlete will consider it a godsend.”
Steinberg said he expected to soon begin advising clients to bank their offspring’s umbilical cord stem cells, something Steinberg did when his own children were born.
In future years, if the use of the stem cell technology in sports becomes more widespread, it leaves open the possibility of professional athletes considering a pregnancy — or artificially creating one — solely to aid their ability to sign another $40 million contract.
“This kind of stem cell news does make me nervous,” said Dr. G. Lynn Lashbrook, an Oregon-based agent, teacher and director of the Sports Management Worldwide Agency. “The athletic world is renown for not controlling its ethical compass.”
At the facilities storing stem cells, where samplings from the best American athletes or their offspring may already be frozen, confidentially agreements prevent officials from revealing the names of clients.
“Our bank does include people with strong athletic backgrounds,” said Dr. Robert Hariri, founder and chief executive of LifebankUSA, one of about 25 private cord blood banks in the United States. Prices for collecting and storing blood vary widely. Dr. Hariri’s facility, in Cedar Knolls, N.J., has about 35,000 units of stem cells; donors can have umbilical cord blood stored for about $1,900, plus $125 a year.
The primary uses to date for cord blood have been in the treatment of leukemia and other life-threatening diseases.
“The focus so far has been on more important things than fixing an athlete’s joints,” Dr. Hariri said. “But we’re well aware of the possibilities and the revolution that is coming.”
In the front lines of the revolution will likely be the best-paid athletes of the world.
“Take David Beckham as an example,” Dr. Lashbrook said, referring to the English soccer star who recently signed a $250 million contract to play for the Los Angeles Galaxy. “If in a few years he had a knee injury, given the money at stake, what would be more paramount than getting him back on the field? His lifeblood and the franchise lifeblood would be dependant on the knee getting better as quickly as possible.
“So it is not a stretch to say that they would turn to the most advanced science available. Wherever it’s available, I might add. History proves that.” An introduction to Adult Stem Cells
June 5th, 2007 No Comments »By Matt Canham
I’m sure you’ve already heard about Stem Cells. Maybe you saw a news story or a read a news article or saw the Presidential address. They are the most widely publicized scientific discovery today and with good reason. How about Embryonic Stem Cells? They have created a great deal of controversy and with good reason. The lure of what Embryonic Stem Cells can do for our health has led to ethical issues surrounding such things as embryo harvesting. One thing remains, Stem Cells represent the future of Health and Wellness as we know it. And they are here to stay.
So what are they?
Stem Cells are master cells, meaning that they can generate many, if not all, of the different tissues of the body. They are with us our entire lives and are released naturally from the bone marrow, but like everything else, the process behind their release slows down with age. When there aren’t as many stem cells in the blood stream, the body can’t repair and renew itself as it once did. These master cells are still contained in the bone marrow in the millions, just not being released as they should.
As this natural release occurs we need to concern ourselves with finding ways to reverse it. The good news is there are 4 things we can do.
Exercise - as we already know, regular exercise is vital to good health
Proper breathing - deep breathing oxygenates the blood and tissues
Good Nutrition - we need nutrients to nourish and water to flush toxins from our cells
Stem cell enhancers - a new product category set to become what antioxidants are today
Stem Cells are the only known source for rebuilding the body and renewing health by restoring lost or degraded cells. They have already been used to help treat things such as Leukemia, AIDS, Alzheimer’s Disease and multiple sclerosis.
They have been used to form new cartilage, grow new corneas to restore sight to the blind, as treatments for stroke victims, and several groups are using adult stem cells with patients to repair damage after heart attacks.
Early clinical trials have also shown initial success in patient treatments for Parkinson’s disease and spinal cord injury. And, the first FDA-approved trial to treat juvenile diabetes in human patients is ready to begin at Harvard Medical School, using adult stem cells.
In short, they are the building blocks of life itself.
Adult versus Embryonic Stem Cells.
Adult Stem Cells is the term given to stem cells after birth which means babies have adult stem cells in their bodies. Embryonic stem cells are simply those from embryos — undifferentiated, or not developed into a specific cell types. Research has shown that embryonic stem cells can develop genetic abnormalities. This is not the case with our own adult stem cells.
For this reason, researchers such as Kursad Turksen in his book ‘Adult Stem Cells’ offer the following wisdom: “Adult stem cell biology is at the forefront of the emerging field of regenerative medicine, offering a source of cells to generate tissues that lack some of the ethical and political impediments inherent in embryonic, fetal, and cloned cells.”
The biggest advantage of using adult stem cells is that the body’s own stem cells can be used, effectively removing the problems of immune rejection or abnormalities.
Adult stem cell science is real.
Adult stem cell research offers the best and clinically proven treatments for a whole host of human diseases and conditions and is helping people overcome these health challenges as you read this article. There are currently over 700 FDA approved clinical trials going on in the United States using adult stem cells but none for embryonic stem cells which is why the future of regenerative health and wellness looks great with Adult stem cells.
Beyond Stem Cell HYPE .. Real HOPE!
Study of bone marrow stem cells in multiple sclerosis
A new pilot clinical trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis has started at Frenchay Hospital.
The aim of the stem cell news trial, conducted by the University of Bristol and North Bristol NHS Trust, is to find out what effects, good or bad, it has on patients with MS, and their disability.
The most announced stem cell news is that bone marrow is known to contain stem cells capable of replacing cells in many types of tissues and organs - and so is of great interest to those working to develop new treatments for many diseases, including those affecting the nervous system.
The potential of such cells to aid repair in multiple sclerosis has been examined in laboratory studies in Bristol and elsewhere but, until now, patients have not been treated in this way. Neil Scolding, Professor of Clinical Neurosciences for North Bristol NHS Trust and the University of Bristol is leading the trial. He said: "We believe this form of adult stem cell treatment, carried out in collaboration with colleagues in the Bone Marrow Transplant Unit at the BRI, will be safe and well-tolerated but, because patients with MS have never had this treatment before, safety has to be proven before any further studies of larger numbers of patients can take place.
"We will therefore be monitoring the stem cell news, along with this small number of patients extremely carefully over the next 9-12 months. Provided, as is envisaged, we do not find serious adverse effects, we hope to raise the funds to undertake a larger study to examine the effectiveness of such treatment in MS."
What does this study involve?
Patients meeting the entry criteria were assessed in the Neurology department and the Burden Centre at Frenchay Hospital to determine general fitness and degree of disability from MS. They also have various types of brain scan, at Frenchay and also at The Hammersmith Hospital in London. Then, at the Bone Marrow Transplant Unit at the BRI, they undergo bone marrow collection under a short general anaesthetic.
The marrow is processed and then delivered back to the patient later the same day via a vein in the arm. Over the following weeks and months, a range of various monitoring tests and scans at Frenchay and in London are then carried out.
The study has been funded by the Adrian Wright bequest, the Myelin Project, the Ipsen Trust, and the Patrick Berthoud Trust. Note: This story has been adapted from a stem cell news release issued by Bristol University
Type 2 Diabetes .. Can Stem Cells Help?
***ADULT STEM CELLS ( AUSTRALIA )***
Patients Create Stem Cell News!
Lots of people die while regulators take years to evaluate new treatments so it is good that there is a loophole for those who are prepared to take a risk.
This ADULT STEM CELL NEWS is being broadcast around the World. Australians with type 2 diabetes are signing up for a costly, unproven stem cell "cure" at a South American clinic. The San Nicolas Clinic says 89per cent of its patients are insulin and medication-free 90 days after being injected with their own stem cells. The treatment costs $US16,000. Some patients who have undergone the same stem-cell therapy for heart disease - which is illegal in all Western countries - say it has given them "a new lease on life". But the world's leading stem-cell scientists warn that patients desperate for a miracle Stem cell news cure are putting themselves at grave risk by undergoing a treatment yet to be fully tested in humans.
The San Nicolas Clinic is bank-rolled by a US energy corporation and is part of the International Clinics of Regenerative Medicine. ICORM director Mike Bartlett was excited about this Adult Stem Cell News. More than 300 patients had been successfully treated for heart disease, diabetes, emphysema and Parkinson's disease at its hospitals in South America and Asia. Mr Bartlett spent last week in Sydney meeting diabetes specialists and cardiologists to encourage them to refer their end-stage patients. To date, the stem cell news studies show 31 Australians with type2 diabetes and seven with heart disease had indicated a wish to travel to Argentina as soon as possible, and a further 208 had made inquiries.This Life-changing Stem Cell News has increased the awareness of Stem cells to more doctors around the world.
Dr Ross Walker, a Sydney Adventist Hospital cardiologist and author of the bestselling book The Cell Factor, was look forward to more exciting stem cell news, and said he would travel to the San Nicolas Clinic early next year to assess this Stem Cell News for himself.. "I believe it is the next big thing in medicine but I want to see solid scientific evidence that it doesn't do any harm before recommending it for the wider population," he said.
Under the patented process, 250 millilitres of a patient's blood is manipulated to yield millions of therapeutic stem cells. The cells are then injected into the diseased organ or tissue. Patients are usually sent home within two days. Numerous patients have testified to this stem cell news "miraculous" effects of the treatment, which uses adult stem cells, not the more ethically-questionable embryonic stem cells. Keith Fanning said the $70,000 he spent flying his dying father, Mick, 75, to Bangkok for stem-cell therapy was "the best $70,000 I ever spent". Oxygen-dependent and barely able to walk before the procedure in July, Mr Fanning's ejection fraction (EF) - the measurement of the capacity at which the heart is pumping - increased so much that he can now breathe, talk and eat on his own. His insulin dependency is also down and his violent shaking from Parkinson's has virtually disappeared. His reaction to this Stem cell news ... "I'm the ultimate sceptic and this stem cell news is the closest thing I've seen to a miracle," he said from his Queensland home.
In October, more stem cell news was created. Lynley White, from Melbourne, spent $45,000 to have 30 stem-cell injections in her heart after traditional drug therapy failed to improve her cardiomyopathy. "My doctors laughed at me and said I had rocks in my head but so far so good. I'm feeling more and more energetic," she said. At 62, she was unlikely to receive the heart transplant she needed to keep going. Of the 120 people who have tried the treatment at Bangkok Heart Hospital, the stem cell news being published ,is that four have died. But Mrs White said her only fear was she would not survive the anaesthetic. "My ejection fraction was getting lower and lower - it got down to 12 when it should be 55 plus - and I thought 'I've got to help myself'," she said. Immediately after treatment, the good stem cell news was that her EF rating was up by 64 per cent.
ADULT STEM CELL NEWS & STEM CELL RESEARCH
Dr Teija Peura, director of human embryonic stem cell laboratories at the Australian Stem Cell Centre, said: "It's understandable that patients who are desperate can't wait for treatment to go through the approval process but it's dangerous because these countries are giving treatment which they don't know how or why [it] works." The International Society for Stem Cell Research said the only stem cell-based therapy with clearly proven efficacy was bone marrow transplantation for blood disorders and leukaemia.
These articles, products, statements, testimonials, reviews, and videos, have not been evaluated by the Food and Drug Administration. They are for educational and informational purposes only and do not constitute medical advice. The opinions expressed herein are those of the authors and ANY products mentioned or referenced,while supported by science or patents, are not intended to diagnose, treat, cure or prevent ANY disease or illness.
For information on supporting your body’s natural ability to release stem cells, and to take advantage of any wellness opportunities involving optimal health ,stem cells, stem cell nutrition and liquid stabilized oxygen …
Subscribe To This Stem Cell Options Blog
